- Home
- ANTX vs NYC Comparison
ANTX vs NYC Comparison
Compare ANTX & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANTX | NYC |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.2M | 25.4M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANTX | NYC |
|---|---|---|
| Price | $1.16 | $11.38 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 137.4K | 6.7K |
| Earning Date | 11-12-2025 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $51,688,000.00 |
| Revenue This Year | N/A | $8.40 |
| Revenue Next Year | N/A | $1.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $7.03 |
| 52 Week High | $1.55 | $16.30 |
Technical Indicators
Market Signals| Indicator | ANTX | NYC |
|---|---|---|
| Relative Strength Index (RSI) | 48.13 | 71.14 |
| Support Level | $1.15 | $9.93 |
| Resistance Level | $1.28 | $11.99 |
| Average True Range (ATR) | 0.08 | 0.75 |
| MACD | -0.01 | 0.14 |
| Stochastic Oscillator | 13.71 | 81.17 |
Price Performance
Historical ComparisonAbout ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.